Wang T, Donahoe P K, Zervos A S
Cutaneous Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.
Science. 1994 Jul 29;265(5172):674-6. doi: 10.1126/science.7518616.
Transforming growth factor-beta (TGF-beta) family members bind to receptors that consist of heteromeric serine-threonine kinase subunits (type I and type II). In a yeast genetic screen, the immunophilin FKBP-12, a target of the macrolides FK506 and rapamycin, interacted with the type I receptor for TGF-beta and with other type I receptors. Deletion, point mutation, and co-immunoprecipitation studies further demonstrated the specificity of the interaction. Excess FK506 competed with type I receptors for binding to FKBP-12, which suggests that these receptors share or overlap the macrolide binding site on FKBP-12, and therefore they may represent its natural ligand. The specific interaction between the type I receptors and FKBP-12 suggests that FKBP-12 may play a role in type I receptor-mediated signaling.
转化生长因子-β(TGF-β)家族成员与由异源丝氨酸-苏氨酸激酶亚基(I型和II型)组成的受体结合。在酵母基因筛选中,亲免素FKBP-12(大环内酯类药物FK506和雷帕霉素的作用靶点)与TGF-β的I型受体以及其他I型受体相互作用。缺失、点突变和免疫共沉淀研究进一步证明了这种相互作用的特异性。过量的FK506与I型受体竞争结合FKBP-12,这表明这些受体共享或重叠FKBP-12上的大环内酯结合位点,因此它们可能代表其天然配体。I型受体与FKBP-12之间的特异性相互作用表明FKBP-12可能在I型受体介导的信号传导中发挥作用。